Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Post by stinkinasonon Oct 05, 2018 1:04pm

94 Views

Post# 28753202

WTF %??

Cote de niveau 2

Cotes de niveau 2 – Cours acheteur
Nombre d'actions		Cours acheteur
6 666 000 actions	6 666 000	0,120
7 464 000 actions	7 464 000	0,115
1 495 500 actions	1 495 500	0,110
2 238 500 actions	2 238 500	0,105
3 407 000 actions	3 407 000	0,100
800 000 actions	800 000	0,095
636 000 actions	636 000	0,090
766 500 actions	766 500	0,085
201 000 actions	201 000	0,080
26 000 actions	26 000	0,075

Cotes de niveau 2 – Cours vendeur
Cours vendeur	Nombre d'actions
0,125	1 436 500	1 436 500 actions
0,130	1 254 500	1 254 500 actions
0,135	1 276 500	1 276 500 actions
0,140	1 122 500	1 122 500 actions
0,145	527 500	527 500 actions
0,150	422 000	422 000 actions
0,155	241 000	241 000 actions
0,160	338 500	338 500 actions
0,165	137 000	137 000 actions
0,170	60 000	60 000 actions